DSGN
Income statement / Annual
Last year (2023), Design Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Design Therapeutics, Inc.'s net income was -$66.86 M.
See Design Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$226.00
|
$834.00
|
| Cost of Revenue |
$537,000.00 |
$466,000.00 |
$129,000.00 |
$5,000.00 |
$1,654.00 |
| Gross Profit |
-$537,000.00 |
-$466,000.00 |
-$129,000.00 |
-$4,774.00 |
-$820.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
-21.12 |
-0.98 |
| Research and Development
Expenses |
$57.06 M
|
$48.61 M
|
$24.78 M
|
$6.06 M
|
$1.65 M
|
| General & Administrative
Expenses |
$21.13 M
|
$18.98 M
|
$11.05 M
|
$2.50 M
|
$1.09 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$21.13 M
|
$18.98 M
|
$11.05 M
|
$2.50 M
|
$1.09 M
|
| Other Expenses |
$0.00 |
$4.29 M |
$298,000.00 |
-$226,000.00 |
-$834,000.00 |
| Operating Expenses |
$78.19 M |
$67.59 M |
$35.83 M |
$8.33 M |
$1.91 M |
| Cost And Expenses |
$78.19 M |
$67.59 M |
$35.83 M |
$8.33 M |
$1.91 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
-$4.69 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$537,000.00
|
$466,000.00
|
$129,000.00
|
$5,000.00
|
$1.91 M
|
| EBITDA |
-$78.19 M
|
-$67.59 M
|
-$35.70 M
|
-$8.33 M
|
-$1.91 M
|
| EBITDA Ratio |
0 |
0 |
0 |
-36836.28 |
-2287.77 |
| Operating Income Ratio
|
0
|
0
|
0
|
-36858.41
|
-2287.77
|
| Total Other
Income/Expenses Net |
$11.33 M
|
$4.29 M
|
$298,000.00
|
$50,000.00
|
-$139,000.00
|
| Income Before Tax |
-$66.86 M |
-$63.31 M |
-$35.53 M |
-$8.28 M |
-$2.05 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
-36637.17
|
-2454.44
|
| Income Tax Expense |
-$537,000.00 |
-$4.69 M |
-$107,558.00 |
-$201,297.00 |
-$1,908.00 |
| Net Income |
-$66.86 M |
-$58.62 M |
-$35.53 M |
-$8.28 M |
-$2.05 M |
| Net Income Ratio |
0 |
0 |
0 |
-36637.17 |
-2454.44 |
| EPS |
-1.19 |
-1.05 |
-0.77 |
-0.3 |
-0.0753 |
| EPS Diluted |
-1.19 |
-1.05 |
-0.77 |
-0.3 |
-0.0753 |
| Weighted Average Shares
Out |
$55.98 M
|
$55.71 M
|
$45.94 M
|
$27.19 M
|
$27.19 M
|
| Weighted Average Shares
Out Diluted |
$55.98 M
|
$55.71 M
|
$45.94 M
|
$27.19 M
|
$27.19 M
|
| Link |
|
|
|
|
|
